Document is current
Any future updates will be listed below
-
Authors
Koopmans, Frank https://orcid.org/0000-0002-4973-5732
Dijkstra, Anke A.
Li, Wei-Ping https://orcid.org/0009-0006-7222-6967
Klaassen, Remco V.
Gouwenberg, Yvonne
Yao, Shuyang https://orcid.org/0000-0001-9669-4470
Bast, Lisa https://orcid.org/0000-0001-8489-3923
Verhage, Matthijs
Karlsson, Robert https://orcid.org/0000-0002-8949-2587
Dwork, Andrew J.
Stockmeier, Craig A. https://orcid.org/0000-0003-1861-1013
Hjerling-Leffler, Jens https://orcid.org/0000-0002-4539-1776
Sullivan, Patrick F. https://orcid.org/0000-0002-6619-873X
Smit, August B. https://orcid.org/0000-0002-2286-1587
- License Information
-
More Information
Article History
Received: 30 November 2024
Accepted: 21 January 2026
First Online: 29 January 2026
Competing interests
: P.F.S. reports the following potentially competing financial interest: Neumora Therapeutics (advisory committee, shareholder). To the best of his knowledge, these are unrelated to this paper/project. The remaining authors declare no competing interests.
